van Doorn PA - Search Results

1

Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress.

Janssens AC, van Doorn PA, de Boer JB, van der Meché FG, Passchier J, Hintzen RQ. Janssens AC, et al. Among authors: van doorn pa, van der meche fg. J Clin Epidemiol. 2004 Feb;57(2):180-6. doi: 10.1016/S0895-4356(03)00260-9. J Clin Epidemiol. 2004. PMID: 15125628

2

Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies.

Merkies IS, Schmitz PI, Van Der Meché FG, Samijn JP, Van Doorn PA. Merkies IS, et al. Among authors: van doorn pa, van der meche fg. Muscle Nerve. 2002 Mar;25(3):370-7. doi: 10.1002/mus.10045. Muscle Nerve. 2002. PMID: 11870713

3

Comparison between impairment and disability scales in immune-mediated polyneuropathies.

Merkies IS, Schmitz PI, Van Der Meché FG, Van Doorn PA. Merkies IS, et al. Among authors: van doorn pa, van der meche fg. Muscle Nerve. 2003 Jul;28(1):93-100. doi: 10.1002/mus.10410. Muscle Nerve. 2003. PMID: 12811779 Clinical Trial.

4

Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients.

Buljevac D, Verkooyen RP, Jacobs BC, Hop W, van der Zwaan LA, van Doorn PA, Hintzen RQ. Buljevac D, et al. Among authors: van der zwaan la, van doorn pa. Ann Neurol. 2003 Dec;54(6):828-31. doi: 10.1002/ana.10759. Ann Neurol. 2003. PMID: 14681894

5

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: van rijs w, van doorn pa. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

6

Fatigue: an important feature of late-onset Pompe disease.

Hagemans ML, van Schie SP, Janssens AC, van Doorn PA, Reuser AJ, van der Ploeg AT. Hagemans ML, et al. Among authors: van der ploeg at, van schie sp, van doorn pa. J Neurol. 2007 Jul;254(7):941-5. doi: 10.1007/s00415-006-0434-2. Epub 2007 Mar 2. J Neurol. 2007. PMID: 17351726 Free PMC article.

7

Health-related quality of life in Guillain-Barré syndrome patients: a systematic review.

Darweesh SK, Polinder S, Mulder MJ, Baena CP, van Leeuwen N, Franco OH, Jacobs BC, van Doorn PA. Darweesh SK, et al. Among authors: van doorn pa, van leeuwen n. J Peripher Nerv Syst. 2014 Mar;19(1):24-35. doi: 10.1111/jns5.12051. J Peripher Nerv Syst. 2014. PMID: 24456426 Review.

8

The epidemiology and risk factors of chronic polyneuropathy.

Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. Hanewinckel R, et al. Among authors: van oijen m, van doorn pa. Eur J Epidemiol. 2016 Jan;31(1):5-20. doi: 10.1007/s10654-015-0094-6. Epub 2015 Dec 23. Eur J Epidemiol. 2016. PMID: 26700499 Free PMC article. Review.

9

Treatment of immune neuropathies.

Van Doorn PA, Garssen MP. Van Doorn PA, et al. Curr Opin Neurol. 2002 Oct;15(5):623-31. doi: 10.1097/00019052-200210000-00014. Curr Opin Neurol. 2002. PMID: 12352007 Review.

10

A clinical prognostic scoring system for Guillain-Barré syndrome.

van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. van Koningsveld R, et al. Among authors: van doorn pa. Lancet Neurol. 2007 Jul;6(7):589-94. doi: 10.1016/S1474-4422(07)70130-8. Lancet Neurol. 2007. PMID: 17537676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page